It’s no longer Trudeau: Canada’s PM resigns
The Intelligence from The Economist
Revolutionizing Drug Development with AI
This chapter explores the escalating costs of pharmaceutical development and the potential of artificial intelligence to transform the process. It highlights advances like AlphaFold in protein structure prediction and the role of generative AI in expediting drug discovery, while also addressing the ongoing challenges in clinical trials.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
